Accuracy in equianalgesic dosing: Conversion dilemmas

被引:146
作者
Anderson, R
Saiers, JH
Abram, S
Schlicht, C
机构
[1] Vet Affairs Med Ctr, Hematol Oncol Serv 111H, Dept Pharm, Albuquerque, NM 87108 USA
[2] Vet Affairs Med Ctr, Med Serv, Albuquerque, NM 87108 USA
[3] Vet Affairs Med Ctr, Dept Anesthesiol, Albuquerque, NM 87108 USA
[4] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Sch Pharm, Albuquerque, NM 87131 USA
关键词
equianalgesic dosing; opioids; chronic pain; palliative care; opioid rotation;
D O I
10.1016/S0885-3924(01)00271-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The clinical benefit and increased application of opioid rotation has focused attention ob efficacy differences opioids and their respective equianalgesic dose rations. Understanding the differences between the opioids is critical to understanding their equianalgesis dose ratios and for adjusting therapy following rotation potencies of these agents as presented in current equianalgesic charts and to provide pharmacologic information to assist the clinician with opioid rotation. (C) U.S. Cancer Pain relief Committee, 2001.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 62 条
[41]  
2-8
[42]  
LEHMANN KA, 1991, ADV PAIN RES THER, V18, P481
[43]   Drug therapy: Pharmacologic treatment of cancer pain [J].
Levy, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1124-1132
[44]  
Makin MK, 1998, PAIN CLINIC, V10, P275
[45]   Rapid switching from morphine to methadone in cancer patients with poor response to morphine [J].
Mercadante, S ;
Casuccio, A ;
Calderone, L .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3307-3312
[46]  
Mercadante S, 1999, CANCER, V86, P1856, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO
[47]  
2-G
[48]   SUBCUTANEOUS FENTANYL AND SUFENTANIL INFUSION SUBSTITUTION FOR MORPHINE INTOLERANCE IN CANCER PAIN MANAGEMENT [J].
PAIX, A ;
COLEMAN, A ;
LEES, J ;
GRIGSON, J ;
BROOKSBANK, M ;
THORNE, D ;
ASHBY, M .
PAIN, 1995, 63 (02) :263-269
[49]  
PORTENOY RK, 1994, CANCER-AM CANCER SOC, V74, P907, DOI 10.1002/1097-0142(19940801)74:3<907::AID-CNCR2820740318>3.0.CO
[50]  
2-#